Amolab
Quantitative ultrasound for childbirth monitoring.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor | €0.0 | round | |
€50.0k | Support Program | ||
| Total Funding | 000k | ||
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | (44 %) | (16 %) | (33 %) | 186 % | 20 % | 59 % | (60 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 102 % | (17 %) | 6 % | 76 % | (28 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 88 % | (19 %) | (12 %) | 51 % | (21 %) | 4 % | 4 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Amolab is a forward-thinking startup that specializes in developing integrated hardware and software solutions for the medical community. The company focuses on creating innovative, safe, automated, and non-invasive technology devices that assist clinicians in their daily tasks. Amolab operates in the global healthcare market, providing advanced technological solutions to hospitals, clinics, and other medical institutions.
The company’s business model revolves around the development and sale of these high-tech medical devices. Amolab generates revenue by selling its products directly to healthcare providers and through partnerships with medical institutions. The company also ensures that its management systems adhere to the guidelines set by the International Organisation for Standardisation (ISO), which helps improve the effectiveness and efficiency of its products and services, ultimately leading to higher customer satisfaction.
Amolab’s recent success includes passing a rigorous test conducted by the Maternal Infant Integrated Care Department DAI of Naples with full marks, showcasing the reliability and effectiveness of its solutions. This achievement underscores the company’s commitment to providing top-notch medical technology that meets the highest standards.
In summary, Amolab is dedicated to serving the global medical community with cutting-edge, automated, and non-invasive technology solutions, aiming to enhance the efficiency and safety of clinical practices.
Keywords: Medical Technology, Healthcare, Innovation, Non-Invasive, Automated Solutions, Clinicians, Global Market, ISO Compliance, Hardware, Software.